Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Avista
New YorkGrowth
40 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
11 people
Schmidt
SeoulSeed–Growth
11 people
Investinor
TrondheimPre-Seed–Growth
43 people
Ireland Strategic Investment Fund
DublinSeed–Late Stage
LG Technology Ventures
Silicon ValleySeed–Growth
23 people
UTEC
TokyoPre-Seed–Growth
19 people
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
Capricorn Venture Partners
LeuvenSeed–Growth$270K – $10.8M
29 people
Sandbox Industries
ChicagoSeed–Growth
34 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Northern Gritstone
ManchesterSeed–Growth
41 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
28 people
5Y Capital
ShanghaiSeed–Growth
22 people
M Ventures
AmsterdamSeed–Growth$10.8M
12 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$63K – $3.8M
13 people
IQ Capital
LondonPre-Seed–Growth$1M – $40M
22 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
40 people
Procuritas
StockholmGrowth
32 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
AIF
New YorkSeed–Growth
39 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
17 people
SHS Capital
TübingenGrowth$10M – $50M
43 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
20 people
Related lists
Growth Investors & VC Firms (4263)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2122)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1378)
Data sourced from public filings and firms' own websites — see our methodology.

































































.jpeg)






































